Bufexamac products require reclassification; unfavourable risk-benefit News item 31 July 2021 Pages: 1 - 1
Association between DPP-4 inhibitors and bullous pemphigoid in US Clinical study 31 July 2021 Pages: 5 - 5
Dolutegravir-related obesity increases adverse pregnancy outcomes Clinical study 31 July 2021 Pages: 6 - 6
Drug interactions with anticoagulants increase risk of events Clinical study 31 July 2021 Pages: 7 - 7
IL17 inhibitors do not increase risk of IBD versus etanercept Clinical study 31 July 2021 Pages: 8 - 8
Vitamin D supplementation improves statin-related myopathy Clinical study 31 July 2021 Pages: 10 - 10